Richard Edward Heyman
Angel · California
Board director at 3 startups that filed Form D raises since late 2024, mostly in California.
- Stages
- Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Apr 2024
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Pelage PharmaceuticalsJun 28, 2023
- SEC Form D: Oric PharmaceuticalsJul 5, 2023
- SEC Form D: Enliven TherapeuticsApr 3, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.